Compare care options for Opioid use disorder

See what we know about each option. We may not have all options. This page does not pick one for you.

Pick up to 4 care options

You can share this page. You do not need an account.

1 selected

What we found

Each option is for Opioid use disorder. Research and local care are different facts.

Buprenorphine-naloxone

What it is

SAMHSA guidance supports buprenorphine treatment within its retained scope; exact products and local availability require separate evidence.

SAMHSA TIP 63: Medications for Opioid Use Disorder · checked Aug 31, 2026

Relationship: supports bounded summary

Scope: country:US

Pointer: /conclusion

Open source

Source: SAMHSA TIP 63: Medications for Opioid Use Disorder. Checked Aug 31, 2026. Scope: country:US. Link: https://www.samhsa.gov/resource/ebp/tip-63-medications-opioid-use-disorder

Why it is on this page

People: people with opioid use disorder

SAMHSA TIP 63: Medications for Opioid Use Disorder · checked Aug 31, 2026

Relationship: medication treatment for opioid use disorder

Scope: country:US

Pointer: /conclusion

Open source

Source: SAMHSA TIP 63: Medications for Opioid Use Disorder. Checked Aug 31, 2026. Scope: country:US. Link: https://www.samhsa.gov/resource/ebp/tip-63-medications-opioid-use-disorder

Why it is on this page

People: people with opioid use disorder

SAMHSA TIP 63: Medications for Opioid Use Disorder · checked Aug 31, 2026

Relationship: medication treatment for opioid use disorder

Scope: country:US

Pointer: /conclusion

Open source

Source: SAMHSA TIP 63: Medications for Opioid Use Disorder. Checked Aug 31, 2026. Scope: country:US. Link: https://www.samhsa.gov/resource/ebp/tip-63-medications-opioid-use-disorder

Why it is on this page

People: people with opioid use disorder

SAMHSA TIP 63: Medications for Opioid Use Disorder · checked Aug 31, 2026

Relationship: medication treatment for opioid use disorder

Scope: country:US

Pointer: /conclusion

Open source

Source: SAMHSA TIP 63: Medications for Opioid Use Disorder. Checked Aug 31, 2026. Scope: country:US. Link: https://www.samhsa.gov/resource/ebp/tip-63-medications-opioid-use-disorder

Why it is on this page

People: people with opioid use disorder

SAMHSA TIP 63: Medications for Opioid Use Disorder · checked Aug 30, 2026

Relationship: medication treatment for opioid use disorder

Scope: country:US

Pointer: /conclusion

Open source

Source: SAMHSA TIP 63: Medications for Opioid Use Disorder. Checked Aug 30, 2026. Scope: country:US. Link: https://www.samhsa.gov/resource/ebp/tip-63-medications-opioid-use-disorder

Why it is on this page

People: people with opioid use disorder

SAMHSA TIP 63: Medications for Opioid Use Disorder · checked Aug 31, 2026

Relationship: medication treatment for opioid use disorder

Scope: country:US

Pointer: /conclusion

Open source

Source: SAMHSA TIP 63: Medications for Opioid Use Disorder. Checked Aug 31, 2026. Scope: country:US. Link: https://www.samhsa.gov/resource/ebp/tip-63-medications-opioid-use-disorder

Research for Opioid use disorder

Research suggests benefit in this exact scope

Published Aug 31, 2026 · revision 11

conclusion

The retained SAMHSA guidance supports buprenorphine treatment for opioid use disorder while preserving product, personal-suitability, and access boundaries.

SAMHSA TIP 63: Medications for Opioid Use Disorder · checked Aug 31, 2026

Relationship: supports bounded conclusion

Scope: country:US

Pointer: /conclusion

Open source

Source: SAMHSA TIP 63: Medications for Opioid Use Disorder. Checked Aug 31, 2026. Scope: country:US. Link: https://www.samhsa.gov/resource/ebp/tip-63-medications-opioid-use-disorder

Compared with the others: Not directly compared. We show each option’s own research.

See the researchFind care

Page link: https://everyoption.org/compare/opioid-use-disorder?treatments=buprenorphine-naloxone